ATLASATLAS fair value
$27.74
Above fair value · 162% premium
Range: $21–$36Fair valuePrice
Bio-Techne (TECH)
Bio-Techne stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$72.60▼ -0.12%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bio-Techne in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bio-Techne
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Bio-Techne's fair value at about $27.74 per share (reasonable range: $21.37 to $36.01). At $72.60, the stock trades 162% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Bio-Techne a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $70.39 and $75.50; in 9 out of 10, between $66.15 and $80.34. Estimated annual volatility is 7%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $11.4B
- P/E ratio
- 62.5
- Dividend yield
- 0.44%
- 52-week high
- $72.75
- 52-week low
- $43.20
- Revenue (12 months)
- $1.2B
- Revenue growth (YoY)
- -0.4%
- Earnings growth (YoY)
- +152.2%
- Gross margin
- 65.8%
- Operating margin
- 22.4%
- Net margin
- 15.0%
- Return on equity
- 9.0%
- Free cash flow (12 months)
- $230M
- Beta
- 1.27
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Bio-Techne sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks TECH has traded between $43.20 and $72.75. Today it is at its high and 68% above its low.
On the business: revenue fell 0.4% year over year; net margin is 15.0%; it trades at 62.5 times earnings.
Its beta is 1.27: it tends to move more than the market, both up and down.
About the company
Bio-Techne Corp. is a global life sciences company that develops, manufactures, and sells reagents, analytical instruments, and precision diagnostics for research, diagnostic, and bioprocessing applications.
Want to see everything about Bio-Techne?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Bio-Techne (TECH) fair value?
About $27.74 per share according to ATLAS (reasonable range: $21.37 to $36.01). With the stock at $72.60, it is 162% above it.
What is the chance TECH goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, TECH ends the month between $70.39 and $75.50.
How big is Bio-Techne and what is its P/E ratio?
Bio-Techne's market capitalization is $11.4B. Its price-to-earnings (P/E) ratio is 62.5: you pay $62.5 for each $1 of yearly earnings.
Does Bio-Techne pay a dividend?
Yes. TECH's current dividend yield is 0.44% at today's price ($72.60).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer